Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China flag China · Delayed Price · Currency is CNY
19.16
+0.40 (2.13%)
Feb 3, 2026, 3:04 PM CST

SHE:002317 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
932.321,3991,252927.671,0161,324
Short-Term Investments
107.77163.69389.1151.7540-
Trading Asset Securities
342.12305.99683.06340.68239.92306.65
Cash & Short-Term Investments
1,3821,8692,3241,4201,2961,630
Cash Growth
-10.22%-19.58%63.66%9.55%-20.49%68.09%
Accounts Receivable
1,218999.6978.31,204792.46955.56
Other Receivables
8.6655.8545.6229.4411.4811.36
Receivables
1,2271,0551,0241,233803.94966.93
Inventory
349.16441.48520.39481.06452.2403.83
Prepaid Expenses
----0-
Other Current Assets
140.896.7492.1100.4119.12132.26
Total Current Assets
3,0993,4633,9613,2352,6723,133
Property, Plant & Equipment
728.07687.36695.91636.82601.24557.97
Long-Term Investments
145.14516.23519.95727.09650.61164.88
Goodwill
6.956.95208.63208.63208.63208.63
Other Intangible Assets
517.06327.11446.7260.4261.28268.09
Long-Term Deferred Tax Assets
21.1929.6942.4547.0346.8936.87
Long-Term Deferred Charges
332.08489.91564.31586.61401.03335.77
Other Long-Term Assets
318.1533.4419.9774.1560.7670.58
Total Assets
5,1675,5536,4595,7754,9024,776
Accounts Payable
90.9193.193.78126.28106.788.78
Accrued Expenses
19.38141.86163.32232.01164.43182.51
Short-Term Debt
402.71303.46621.49587.6190481
Current Portion of Long-Term Debt
--2.09221210
Current Portion of Leases
127.171.662.722.551.71-
Current Income Taxes Payable
50.944.9212.4613.611.510.94
Current Unearned Revenue
21.1820.0825.9145.2418.8525.96
Other Current Liabilities
117.93638.3993.5479.042930.38
Total Current Liabilities
830.221,2031,0151,108524.2819.57
Long-Term Debt
--97286308225
Long-Term Leases
6.450.31.34.025.27-
Long-Term Unearned Revenue
154.64161.94132.6755.5732.7439.44
Long-Term Deferred Tax Liabilities
38.0638.948.9570.2359.9665.58
Other Long-Term Liabilities
12.14138.76637.61434.68433.67-
Total Liabilities
1,0421,5431,9331,9591,3641,150
Common Stock
849.93851.56853.35814.43814.46814.46
Additional Paid-In Capital
1,8151,7801,8071,3101,3211,466
Retained Earnings
1,3171,2371,7061,6041,4441,327
Treasury Stock
--8.1-67.14-80.36-151.6-100.01
Comprehensive Income & Other
48.2754.8657.3654.4547.5218.04
Total Common Equity
4,0303,9154,3563,7033,4763,525
Minority Interest
95.8695.34169.37113.7262.49101.51
Shareholders' Equity
4,1264,0104,5263,8163,5383,626
Total Liabilities & Equity
5,1675,5536,4595,7754,9024,776
Total Debt
536.33305.43724.6902.17516.98716
Net Cash (Debt)
845.871,5641,600517.93779.3914.29
Net Cash Growth
-44.99%-2.24%208.85%-33.54%-14.76%1109.04%
Net Cash Per Share
1.011.881.940.640.981.14
Filing Date Shares Outstanding
849.93846.01847.8808.88797.43802.99
Total Common Shares Outstanding
849.93846.01847.8808.88797.43803.36
Working Capital
2,2692,2592,9452,1262,1472,314
Book Value Per Share
4.744.635.144.584.364.39
Tangible Book Value
3,5063,5813,7013,2343,0063,048
Tangible Book Value Per Share
4.134.234.374.003.773.79
Buildings
-561.69527.39506.28474.51460.07
Machinery
-734.13638.4600.95568.8531.19
Construction In Progress
-27.58123.5582.0356.4722.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.